New device aims to ease stubborn hip pain without surgery
NCT ID NCT07568015
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This study tests a new device called ReneuRx, which targets specific nerves around the hip, against a standard steroid injection for people with long-lasting lateral hip pain. About 100 adults aged 22 to 80 with moderate to severe pain will take part. Researchers will track pain levels and safety for up to a year to see if ReneuRx offers better relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ReneuRx device (nerve-targeting injection) and triamcinolone acetate (corticosteroid injection)
What this could lead to
If it works, this could offer a new, targeted option for people with chronic hip pain who haven't found relief from standard treatments.
What could go wrong
This is an early-stage trial with only 100 participants, so results may not apply to everyone. The device is new, and its long-term safety and effectiveness are not yet proven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GREATER TROCHANTERIC PAIN SYNDROME are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
All-American Orthopedic & Sports
Houston, Texas, 77058, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Emory Orthopedics and Spine Center
Johns Creek, Georgia, 30097, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Healthcare Outcomes Performance Company
Sun City, Arizona, 85023, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mass General Brigham
Chestnut Hill, Massachusetts, 02467, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ochsner Health Center
New Orleans, Louisiana, 70121, United States
Contact Email: •••••@•••••
Contact
-
Pain Diagnostics & Interventional Care
Sewickley, Pennsylvania, 15143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rothman Orthopaedics
King of Prussia, Pennsylvania, 19406, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Skylight Health Research
Burlington, Massachusetts, 01803, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Orthopaedic Center
Tulsa, Oklahoma, 74137, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Virtua Health
Sewell, New Jersey, 08080, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact